ES2151607T3 - Factor 12 de crecimiento y de diferenciacion. - Google Patents

Factor 12 de crecimiento y de diferenciacion.

Info

Publication number
ES2151607T3
ES2151607T3 ES95928062T ES95928062T ES2151607T3 ES 2151607 T3 ES2151607 T3 ES 2151607T3 ES 95928062 T ES95928062 T ES 95928062T ES 95928062 T ES95928062 T ES 95928062T ES 2151607 T3 ES2151607 T3 ES 2151607T3
Authority
ES
Spain
Prior art keywords
differentiation factor
growth
polyucleotidic
amino acid
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95928062T
Other languages
English (en)
Inventor
Se-Jin Lee
Aurora F Esquela
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Johns Hopkins University
School of Medicine of Johns Hopkins University
Original Assignee
Johns Hopkins University
School of Medicine of Johns Hopkins University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/274,215 external-priority patent/US5831054A/en
Application filed by Johns Hopkins University, School of Medicine of Johns Hopkins University filed Critical Johns Hopkins University
Application granted granted Critical
Publication of ES2151607T3 publication Critical patent/ES2151607T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

SE DESCRIBE EL FACTOR-12 DE DIFERENCIACION DEL CRECIMIENTO, JUNTO CON SU SECUENCIA POLINUCLEOTIDICA Y SU SECUENCIA AMINOACIDA. ASIMISMO, SE DESCRIBEN METODOS TERAPEUTICOS Y DE DIAGNOSTICO, PARA UTILIZAR LAS SECUENCIA POLINUCLEOTIDICA Y AMINOACIDA DE GDF-12.
ES95928062T 1994-07-13 1995-07-12 Factor 12 de crecimiento y de diferenciacion. Expired - Lifetime ES2151607T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/274,215 US5831054A (en) 1994-07-13 1994-07-13 Polynucleotide encoding growth differentiation factor-12
US31137094A 1994-09-26 1994-09-26

Publications (1)

Publication Number Publication Date
ES2151607T3 true ES2151607T3 (es) 2001-01-01

Family

ID=26956672

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95928062T Expired - Lifetime ES2151607T3 (es) 1994-07-13 1995-07-12 Factor 12 de crecimiento y de diferenciacion.

Country Status (11)

Country Link
US (1) US5929213A (es)
EP (1) EP0770089B1 (es)
JP (1) JPH10503362A (es)
AT (1) ATE196147T1 (es)
CA (1) CA2195246A1 (es)
DE (1) DE69518760T2 (es)
DK (1) DK0770089T3 (es)
ES (1) ES2151607T3 (es)
GR (1) GR3034772T3 (es)
PT (1) PT770089E (es)
WO (1) WO1996002559A1 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5846770A (en) * 1994-11-22 1998-12-08 Genetics Institute, Inc. DNA molecules encoding human chordin
US5965403A (en) 1996-09-18 1999-10-12 Genetics Institute, Inc. Nucleic acids encoding bone morphogenic protein-16 (BMP-16)
US20020052026A1 (en) 1997-10-08 2002-05-02 Steven M. Vicik Methods of refolding proteins
US6027917A (en) 1997-12-10 2000-02-22 Genetics Institute, Inc. Bone morphogenetic protein (BMP)-17 and BMP-18 compositions
US6727224B1 (en) 1999-02-01 2004-04-27 Genetics Institute, Llc. Methods and compositions for healing and repair of articular cartilage
IL150198A0 (en) * 1999-12-15 2002-12-01 Res Dev Foundation Betaglycan as an inhibin receptor and uses thereof
TWI267378B (en) 2001-06-08 2006-12-01 Wyeth Corp Calcium phosphate delivery vehicles for osteoinductive proteins
BRPI0413720A (pt) 2003-09-12 2006-10-17 Wyeth Corp bastões e pastas sólidas de fosfato de cálcio injetável para liberação de proteìnas osteogênicas
CA2563374A1 (en) 2004-04-27 2005-12-08 Research Development Foundation Antagonism of tgf-.beta.superfamily receptor signaling
US7799754B2 (en) 2004-10-14 2010-09-21 Biomimetic Therapeutics, Inc. Compositions and methods for treating bone
US7473678B2 (en) 2004-10-14 2009-01-06 Biomimetic Therapeutics, Inc. Platelet-derived growth factor compositions and methods of use thereof
US8147860B2 (en) 2005-12-06 2012-04-03 Etex Corporation Porous calcium phosphate bone material
ES2664229T3 (es) 2006-06-30 2018-04-18 Biomimetic Therapeutics, Llc Composiciones y métodos de biomatriz-PDGF para el tratamiento de lesiones del manguito rotador
US9161967B2 (en) 2006-06-30 2015-10-20 Biomimetic Therapeutics, Llc Compositions and methods for treating the vertebral column
US8524265B2 (en) 2006-08-17 2013-09-03 Warsaw Orthopedic, Inc. Medical implant sheets useful for tissue regeneration
BR122020000059B8 (pt) 2008-09-09 2021-06-22 Biomimetic Therapeutics Inc composição que compreende uma matriz biocompatível e um fator de crescimento derivado de plaqueta e kit
US8609127B2 (en) 2009-04-03 2013-12-17 Warsaw Orthopedic, Inc. Medical implant with bioactive material and method of making the medical implant
US20110002897A1 (en) 2009-06-11 2011-01-06 Burnham Institute For Medical Research Directed differentiation of stem cells
WO2011103598A1 (en) 2010-02-22 2011-08-25 Biomimetic Therapeutics, Inc. Platelet-derived growth factor compositions and methods for the treatment of tendinopathies
US10034945B2 (en) 2012-07-13 2018-07-31 Trustees Of Tufts College Silk powder compaction for production of constructs with high mechanical strength and stiffness
CN115073625B (zh) 2015-10-26 2024-01-16 哈佛学院院长等 还原和氧化的多糖及其使用方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3193050B2 (ja) * 1992-02-12 2001-07-30 ビオファルム ゲゼルシャフト ツア ビオテヒノロ ギッシェン エントヴィックルング フォン ファル マカ ミット ベシュレンクテル ハフツング 新規の増殖／分化因子をコード化するｄｎａ配列

Also Published As

Publication number Publication date
DE69518760D1 (de) 2000-10-12
WO1996002559A1 (en) 1996-02-01
CA2195246A1 (en) 1996-02-01
EP0770089A1 (en) 1997-05-02
DK0770089T3 (da) 2000-10-23
EP0770089A4 (en) 1997-06-18
EP0770089B1 (en) 2000-09-06
DE69518760T2 (de) 2001-05-23
PT770089E (pt) 2001-02-28
US5929213A (en) 1999-07-27
JPH10503362A (ja) 1998-03-31
ATE196147T1 (de) 2000-09-15
GR3034772T3 (en) 2001-02-28

Similar Documents

Publication Publication Date Title
ES2151607T3 (es) Factor 12 de crecimiento y de diferenciacion.
BR9910251A (pt) Estimulação hematopoiética
ES2179077T3 (es) Acido glutamico decarboxilasa clonada.
NO844579L (no) Enzymresistente immunomodulerende peptider.
DK0751959T3 (da) Modificerede polypeptider med forøget biologisk aktivitet
RU95114376A (ru) Нитроэфиры, обладающие фармакологической активностью, и способ их получения
DE69024965T2 (de) Dehydrodidemnin b
BR9403783A (pt) Uso de uma composição cosmética
ES8800160A1 (es) Procedimiento de obtencion de acidos quinolincarboxilicos con propiedades antibacteriales.
DE3689191T2 (de) Gereinigtes protein mit angiogenischer wirkung und dessen herstellung.
ATE81776T1 (de) Verwendung von chinolon und naphthyridinantibiotika zur herstellung von ophthalmischen arzneimitteln.
RU94041224A (ru) Пептиды с органозащитной активностью, фармацевтическая композиция на их основе и их применение в терапии
ES2063202T3 (es) Nuevas 5,11-dihidro-6h-dipirido(3,2-b:2',3'-e)(1,4)diazepin-6-onas y -tionas y su uso en la prevencion o tratamiento del sida.
FI893681A (fi) N-2,3-butadienyltri- och tetra-aminoalkanderivat.
ES2177625T3 (es) Citoquina cc-1 humana circulante.
FI931204A (fi) Nya, saosom lipooxigenasinhibitorer verkande aminobensosultamderivat
ES2066096T3 (es) 4-bencil-5-fenil-2,4-dihidro-3h-1,2,4-triazol-3-onas y su uso como anticonvulsivos.
ES2076141T3 (es) 5-aril-3h-1,2,4-triazol-3-onas y su uso como anticonvulsivos.
ATE128964T1 (de) Anwendung von beta-alethin in zellkultur und therapie.
NO902104D0 (no) Kosmetisk blanding.
DE3764559D1 (de) 4-benzyloxy-3-pyrrolin-2-on-1-yl-acetamid, dessen herstellung und verwendung.
ATE62789T1 (de) Mittel zur bekaempfung von phytopathogenen mikroben.
ES2150034T3 (es) Empleo de las 2-aminotetralinas substituidas en 6,7 para la preparacion de composiciones farmaceuticas de utilidad para el tratamiento del choque septico, y composiciones farmaceuticas antipireticas y antiinflamatorias.
BR9704964A (pt) Uso de sulbutiamina para obter composições farmacêuticas úteis no tratamento de algumas pertubações psicomotoras e psico-intelectuais
ES2033927T3 (es) Utilizacion de la forma farmaceutica de "gel" conteniendo acido n-(2,6-cicloro-m-tolil)-antranilico (acido meclofenamico) utilizable en terapia de uso topico.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 770089

Country of ref document: ES